Pharmacokinetics of Single Doses of BILR 355 BS Given With Ritonavir in Healthy Male Volunteers
NCT02253953 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 62
Last updated 2014-10-01
Summary
Assessment of the effect of two times oral 100 mg ritonavir capsules on pharmacokinetics of a single dose of BILR 355 BS dissolved in PEG 400
Conditions
- Healthy
Interventions
- DRUG
-
BILR 355 BS, D1
- DRUG
-
BILR 355 BS, D2
- DRUG
-
BILR 355 BS, D3
- DRUG
-
BILR 355 BS, D4
- DRUG
-
BILR 355 BS, D5
- DRUG
-
BILR 355 BS, D6
- DRUG
-
BILR 355 BS, D7
- DRUG
-
BILR 355 BS, D8
- DRUG
-
BILR 355 BS, D10
- DRUG
- OTHER
-
high-fat breakfast
- DRUG
-
Ritonavir
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Max Age
- 50 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2002-11-30
- Primary Completion
- 2003-12-31
More Related Trials
-
Effect of Different Boosting Agents on Pharmacokinetics of BILR 355 BS Dissolved in Polyethylene Glycol 400 (PEG 400) in Healthy Male Volunteers
NCT02257008 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability of BI 1356 After Co-administration With Ritonavir Compared to the Bioavailability of BI 1356 Alone in Healthy Male Volunteers
NCT02183441 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability of a Single-dose Administration of BIBW 2992 and Multiple-dose Administration of Ritonavir in Healthy Volunteers
NCT02171754 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Tipranavir (With Ritonavir) Capsule and Liquid Formulation on Cytochrome P450 and P-glycoprotein Activity in Healthy Volunteers
NCT02243553 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety, Tolerability and Preliminary Pharmacokinetics of BILR 355 BS Single-rising Dose Study in Healthy Male Volunteers
NCT02254538 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of Tipranavir/Ritonavir and Its Metabolites in Healthy Male Subjects
NCT02253797 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Effect of Ritonavir on the Single-Dose Pharmacokinetics of JNJ-61393215 in Healthy Participants
NCT03593954 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Interaction Between TRUVADA™ and BILR 355 BS Plus Ritonavir in Healthy Volunteers
NCT02253901 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Pharmacokinetics, and Pharmacodynamics of BIRT 2584 XX in Healthy Male Volunteers
NCT02259894 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of BIBB 515 BS and Effect of Food After Oral Administration in Healthy Subjects
NCT02266498 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of Increasing Repeated Doses of BIIF 1149 BS in Healthy Male Volunteers
NCT02203487 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetics of Single Rising Oral Doses of BI 224436 ZW in Healthy Male Volunteers.
NCT02183662 ·Status: COMPLETED ·Phase: PHASE1
-
Metabolism and Pharmacokinetics of [14C]-BIIL 284 BS in Healthy Volunteers
NCT02266550 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability of Tipranavir/Ritonavir Paediatric Solution Compared to Tipranavir/Ritonavir Capsules in Healthy Female and Male Subjects
NCT02251158 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics of Single Rising Oral Doses of BI 1181181 in Healthy Male Volunteers, Including Investigation of the Effect of Food on the Bioavailability of BI 1181181
NCT02044406 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Relative Bioavailability of 11634 Immediate Release Tablet in Healthy Male Volunteers
NCT02214927 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence of Two Different Oral Solutions Tipranavir Administered in Combination With Ritonavir to Healthy Volunteers
NCT02244190 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetic And Bioavailability Study of Intravenous Danoprevir in Healthy Volunteers
NCT01654211 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Pharmacokinetic Interaction Between Kaletra® (LPV/r) and BILR 355 BS Plus Ritonavir in Healthy Subjects
NCT02256826 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of The Relative Bioavailability of Ritonavir-Boosted Danoprevir Fixed Dose Combination Tablets in Healthy Volunteers
NCT01592318 ·Status: COMPLETED ·Phase: PHASE1
-
Metabolism and Pharmacokinetics of [14C]-BIBR 953 ZW After Administration of Single Doses of [14C]-BIBR 953 ZW Intravenously or [14C]-BIBR 1048 Oral Solution in Healthy Male Volunteers
NCT02171442 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 11634 Solution in Healthy Male Volunteers
NCT02214914 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability and Pharmacokinetics of BI 135585 XX Administered as Tablet With and Without Food
NCT01286571 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability Study of Nirmatrelvir/Ritonavir 4 Different Fixed Dose Combination Tablets Relative to the Commercial Tablets in Healthy Participants
NCT05525910 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Pharmacokinetics and Pharmacodynamics of BIRT 1696 BS in Healthy Human Subjects
NCT02254096 ·Status: COMPLETED ·Phase: PHASE1